Bobby Gaspar - Jun 1, 2022 Form 4 Insider Report for Orchard Therapeutics plc (ORTX)

Role
Chief Executive Officer, Director
Signature
/s/ Bobby Gaspar
Stock symbol
ORTX
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/3/2022, 08:00 AM
Previous filing
Apr 5, 2022
Next filing
Oct 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORTX Stock Option (Right to Buy) Award $0 +423K $0.00 423K Jun 1, 2022 Ordinary Shares 423K $0.46 Direct F1, F2
transaction ORTX Stock Option (Right to Buy) Award $0 +427K $0.00 427K Jun 1, 2022 Ordinary Shares 427K $0.57 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vested on March 1, 2022.
F2 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.